Commercial FIT Capable of Similar Diagnostic Results as New Stool DNA Test
Disparities Persist in CRC Screening, Management Between High-, Low-Income Countries
Overall, Progression-Free Survival in Colon Cancer Indicated Through Visceral Proteins
Contributor: An Urgent Call to Action as Colorectal Cancer Rates Skyrocket Among Young People
A Look at Cancers Where Biomarkers Are Needed
Dr Ajay Goel Explains Effectiveness of Liquid Biopsies, Tissue-Based Biomarkers in Treating CRC
Dr Ajay Goel Discusses New Methods of Testing for EOCRC, Recurrence
Botensilimab and Balstilimab in Refractory Microsatellite Stable (MSS) mCRC
Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Utilizing RWE to Address Unmet Needs for CRC
ASCO GI 2023: SUNLIGHT Study
Neoadjuvant Immunotherapy Promising in CRC, but Long-term Data Needed, Says Dr Kristen Ciombor
Dr Kristen Ciombor: Neoadjuvant Immunotherapy in CRC Reduces Need for Other Treatments
Dr Kristen Ciombor on Precision Medicine Approaches in Colorectal Cancer
OS Disparity, Driver Gene Variations by Race and Ethnicity Seen in CRC
Updated Colonoscopy Guidelines Have Implications on Doctors, Patients Alike